[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341140-105":59,"doc-detail-341140-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","mitochondria-inside-acute-myeloid-leukemia-cells-hydrolyze-atp-to-resist-chemotherapy","Mitochondria inside acute myeloid leukemia cells hydrolyze ATP to resist chemotherapy","","Despite early optimism, therapeutics targeting oxidative phosphorylation (OxPhos) have faced clinical setbacks due to difficulty distinguishing healthy from cancerous mitochondria. This study describes a mitochondria-specific bioenergetic mechanism in acute myeloid leukemia (AML) cells: cancerous mitochondria consume matrix ATP to maintain inner membrane polarization while reversing ATP synthase activity under OxPhos-damaging chemotherapy stress. Venetoclax-mediated BCL-2 inhibition blocks OxPhos flux without depolarization. Resistance is reinforced by ATP5IF1 and respiratory complex downregulation, making matrix ATP consumption a druggable intrinsic vulnerability.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mitochondria-inside-acute-myeloid-leukemia-cells-hydrolyze-atp-to-resist-chemotherapy/341140/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mitochondria-inside-acute-myeloid-leukemia-cells-hydrolyze-atp-to-resist-chemotherapy/341140.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why have OxPhos-targeting therapeutics struggled in the clinic?","Question",{"text":113,"@type":114},"They have faced setbacks because therapies often cannot reliably distinguish healthy mitochondria from cancerous mitochondria.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What bioenergetic mechanism do AML mitochondria use to resist chemotherapy?",{"text":118,"@type":114},"AML mitochondria hydrolyze ATP by consuming matrix ATP to sustain inner membrane polarization, allowing survival under bioenergetic stress.",{"name":120,"@type":111,"acceptedAnswer":121},"How does venetoclax affect OxPhos flux and mitochondrial membrane potential in AML cells?",{"text":122,"@type":114},"Targeted inhibition of BCL-2 with venetoclax abolishes OxPhos flux without impacting mitochondrial membrane potential in the studied cells.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},341140,1790211010,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":24,"preview_urls":147},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","bioRxiv preprint doi: [https://doi.org/10.1101/2024.04.12.589110](https://doi.org/10.1101/2024.04.12.589110); this version posted April 15, 2024. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made  \navailable under aCC-BY-NC-ND 4.0 International license.  \nMitochondria inside acute myeloid leukemia cells hydrolyze ATP to resist chemotherapy  \nJames T Hagen 1,2 , Mclane M Montgomery 1,2 , Raphael T Aruleba 1,2 , Brett R Chrest 1,2 , Thomas D Green 1,2 , Miki Kassai2,3 , Tonya N Zeczycki3 , Cameron A Schmidt2,4 , Debajit Bhowmick5 , Su-Fern Tan6,7 , David J Feith6,7 , Charles E Chalfant6,7,8,9 , Thomas P Loughran Jr6,7 , Darla Liles 10 , Mark D Minden 11 , Aaron D Schimmer11 , Myles C Cabot2,3 , Joseph M Mclung 1,2,12 , and Kelsey H Fisher-Wellman1,2,13,*  \n1 Department of Physiology, Brody School of Medicine, East Carolina University, Greenville, NC 2 East Carolina Diabetes and Obesity Institute, East Carolina University, Greenville, NC  \n3 Department of Biochemistry and Molecular Biology, Brody School of Medicine, East Carolina University, Greenville, NC  \n4 Department of Biology , East Carolina University, Greenville, NC  \n5 Flow Cytometry Core Facility, Brody School of Medicine at East Carolina University, Greenville, NC 6 Department of Medicine, Hematology/Oncology, University of Virginia School of Medicine, Charlottesville, VA 7 University of Virginia Cancer Center, Charlottesville, VA  \n8 Department of Cell Biology, University of Virginia, Charlottesville, VA  \n9 Research Service, Richmond Veterans Administration Medical Center, Richmond, VA 10 Department of Internal Medicine, Brody School of Medicine, East Carolina University, Greenville, NC 11 Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.  \n12 Department of Cardiovascular Sciences, Brody School of Medicine, East Carolina University, Greenville, NC 13 UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC  \n* To whom correspondence should be addressed: Kelsey H. Fisher-Wellman [fisherwellmank17@ecu.edu](fisherwellmank17@ecu.edu)  \nEast Carolina Diabetes and Obesity Institute, 115 Heart Drive, Greenville, NC 27834 USA Telephone: 252-744-2585  \nFax: 252-744-0462  \nABSTRACT  \nDespite early optimism, therapeutics targeting oxidative phosphorylation (OxPhos) have faced clinical setbacks, stemming from their inability to distinguish healthy from cancerous mitochondria. Herein, we describe an actionable bioenergetic mechanism unique to cancerous mitochondria inside acute myeloid leukemia (AML) cells. Unlike healthy cells which couple respiration to the synthesis of ATP, AML mitochondria were discovered to support inner membrane polarization by consuming ATP. Because matrix ATP consumption allows cells to survive bioenergetic stress, we hypothesized that AML cells may resist cell death induced by OxPhos damaging chemotherapy by reversing the ATP synthase reaction. In support of this, targeted inhibition of BCL-2 with venetoclax abolished OxPhos flux without impacting mitochondrial membrane potential. In surviving AML cells, sustained polarization of the mitochondrial inner membrane was dependent on matrix ATP consumption. Mitochondrial ATP consumption was further enhanced in AML cells made refractory to venetoclax, consequential to downregulations in both the proton-pumping respiratory complexes , as well as the endogenous F 1-ATPase inhibitor ATP5IF1 . In treatment-naive AML, ATP5IF1 knockdown was sufficient to drive venetoclax resistance, while ATP5IF1 overexpression impaired F1-ATPase activity and heightened sensitivity to venetoclax. Collectively, our data identify matrix ATP consumption as a cancer-cell intrinsic bioenergetic vulnerability actionable in the context of mitochondrial damaging chemotherapy.  \nbioRxiv preprint doi: [https://doi.or","cbCainusytmNEe4h","https://ap.wps.com/l/cbCainusytmNEe4h","pdf",15413128,42,"English","# Abstract\n# Introduction","[{\"question\":\"Why have OxPhos-targeting therapeutics struggled in the clinic?\",\"answer\":\"They have faced setbacks because therapies often cannot reliably distinguish healthy mitochondria from cancerous mitochondria.\"},{\"question\":\"What bioenergetic mechanism do AML mitochondria use to resist chemotherapy?\",\"answer\":\"AML mitochondria hydrolyze ATP by consuming matrix ATP to sustain inner membrane polarization, allowing survival under bioenergetic stress.\"},{\"question\":\"How does venetoclax affect OxPhos flux and mitochondrial membrane potential in AML cells?\",\"answer\":\"Targeted inhibition of BCL-2 with venetoclax abolishes OxPhos flux without impacting mitochondrial membrane potential in the studied cells.\"}]","Mitochondria inside acute myeloid leukemia cells hydrolyze ATP to resist chemotherapy | PDF",1790040542,106,[148,152,156,160,164],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1b797487e9c82b74aa33c65c94e90224.webp",983,1272,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d7c6f73bb0fe5d2be172e9f1f35341fe.webp",982,1270,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b459662e3e2753ccedd618fa60c6c5a.webp",981,1269,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e246c712d01bdceaae7f3c5612b47131.webp",980,1268,{"page_no":24,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bb39aeada02a19ed6e135ced0d709e06.webp",979,1267]